United Capital Financial Advisors’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$250K Buy
+1,666
New +$181K ﹤0.01% 1447
2021
Q4
– Sell
-11,100
Closed -$1.39M – 1220
2021
Q3
$1.39M Buy
11,100
+1,133
+11% +$135K 0.01% 598
2021
Q2
$1.24M Buy
9,967
+600
+6% +$80.7K 0.01% 642
2021
Q1
$1.43M Buy
9,367
+1,755
+23% +$265K 0.01% 579
2020
Q4
$981K Buy
+7,612
New +$876K 0.01% 681
2020
Q1
– Sell
-2,791
Closed -$218K – 1262
2019
Q4
$218K Sell
2,791
-477
-15% -$34.4K ﹤0.01% 1254
2019
Q3
$209K Sell
3,268
-140
-4% -$12.3K ﹤0.01% 1180
2019
Q2
$294K Buy
3,408
+58
+2% +$4.43K ﹤0.01% 1222
2019
Q1
$257K Buy
+3,350
New +$186K ﹤0.01% 1181

Other funds holding GH

United Capital Financial Advisors's GH Position: Q2 2026 in Review

United Capital Financial Advisors opened a new position in Guardant Health (GH) in Q2 2026: 1,666 shares worth $250K. The stake represents ﹤0.01% of the portfolio and ranks #1447 among its holdings. This is a return to the name: United Capital Financial Advisors previously reported a position in GH as recently as Q3 2021.

United Capital Financial Advisors first reported a position in GH in Q1 2019 and has held it in 9 quarters since. The position peaked at $1.43M in Q1 2021. 601 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • United Capital Financial Advisors held 1,666 shares of Guardant Health worth $250K as of Q2 2026.
  • Guardant Health was a new United Capital Financial Advisors position in Q2 2026.
  • Guardant Health made up ﹤0.01% of United Capital Financial Advisors's portfolio in Q2 2026, its #1447 holding.
  • United Capital Financial Advisors first reported a position in Guardant Health in Q1 2019 and has held it in 9 quarters since.
  • United Capital Financial Advisors's Guardant Health position peaked at $1.43M in Q1 2021.
  • 601 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on United Capital Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.